Substance / Medication

Terfenadine

Overview

Active Ingredient
terfenadine
RxNorm CUI
42330

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Liquid extraction surface analysis mass spectrometry (LESA-MS) as a novel profiling tool for drug distribution and metabolism analysis: the terfenadine example.
Eikel Daniel, Vavrek Marissa, Smith Sheri et al. · Rapid Commun Mass Spectrom · 2011
PMID: 22095508Observational
Molecular determinants of hERG channel block by terfenadine and cisapride.
Kamiya Kaichiro, Niwa Ryoko, Morishima Mikio et al. · J Pharmacol Sci · 2008
PMID: 18987434ObservationalFull text (PMC)
Terfenadine induces thymocyte apoptosis via mitochondrial pathway.
Enomoto Riyo, Komai Tomoe, Yoshida Yukari et al. · Eur J Pharmacol · 2004
PMID: 15288570Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Terfenadine (substance)
SNOMED CT
387089004
UMLS CUI
C0085173
RxNorm CUI
42330

Clinical Data

This intervention maps to 5 entities in the Healos knowledge graph.

5
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.